ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
39 announcements with these filters
Laxmi Dental's 60%-owned Kids-e-Dental received EU MDR and ISO 13485 certificates from TÜV SÜD. The certificates allow EU marketing of its dental products after regulatory formalities.
Laxmi Dental reported record quarterly revenue driven by international expansion and digital adoption.
Laxmi Dental posted record Q2FY27 revenue of Rs 795.2 million, with EBITDA up 38.5% year-on-year. Its consolidated PAT after JV share stood at Rs 100.4 million.
Q2FY27 revenue ₹79.5 Cr (+10% YoY), a record quarter. EBITDA margin 19.2%, PAT ₹10.0 Cr (+17.6%). H1FY27 revenue ₹154.2 Cr (+11.9%).
Laxmi Dental Ltd reported revenue from operations of ₹79.5 Cr (+10.0% YoY) and net profit of ₹10 Cr (+17.6% YoY) for Q2 FY27.
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Laxmi Dental's subsidiary received a tariff refund of ₹5.92 Crore from U.S. Customs following a regulatory change regarding excess tariffs collected.
Laxmi Dental Limited's subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of approximately INR 5.92 Crore from U.S. Customs and Border Protection.
The filing contains the quarterly shareholding pattern for Laxmi Dental Ltd as of September 30, 2026, submitted in compliance with SEBI Regulation 31(1)(b).
Laxmi Dental submitted the Monitoring Agency Report for the quarter ended September 30, 2026, confirming utilization of IPO proceeds is in line with stated objects.
Laxmi Dental Limited approved membership in 'Leelaben Foundation', a Section 8 company, to promote CSR and rural dental facilities. The board also noted compliance fine payments.
Laxmi Dental received NSE and BSE approvals for listing 7,911 ESOP equity shares. The shares will trade from September 18, 2026.
Laxmi Dental Limited has announced its 22nd Annual General Meeting scheduled for September 25, 2026, and submitted its Annual Report for FY 2025-26.
Laxmi Dental Limited has scheduled its 22nd Annual General Meeting for September 25, 2026, via video conferencing. The agenda includes proposed variation of IPO proceeds utilization.
Laxmi Dental Limited has allotted equity shares under its ESOP/ESPS scheme. This corporate action updates the company's paid-up share capital.
Laxmi Dental Ltd approved the allotment of 7,911 equity shares under ESOP 2024. The board also proposed varying IPO objects and extending utilization timelines, pending shareholder approval.
Laxmi Dental reported record Q1 revenue driven by international expansion and scanner adoption, though higher operating costs and employee expenses tempered overall margin gains.
Laxmi Dental reported its highest-ever quarterly revenue of ₹74.7 Cr in Q1FY27, up 13.9% YoY. Strategy focuses on high-margin metal-free zirconia crowns and international expansion.
Laxmi Dental Limited reported the surrender and cancellation of 1,636 employee stock options (ESOPs). The company updated its share capital structure to reflect these changes.
Laxmi Dental reported Q1 FY27 revenue of ₹74.7 crore, up 13.9% year-on-year. Growth was driven by strong momentum in their dental laboratory and aligner solutions businesses.
Laxmi Dental Limited has filed the Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of its IPO proceeds.
Laxmi Dental Ltd reported revenue from operations of ₹74.7 Cr (+13.9% YoY) and net profit of ₹10.3 Cr (+24.1% YoY) for Q1 FY27.
Laxmi Dental Limited has scheduled a board meeting for August 11, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Laxmi Dental Ltd submitted its quarterly shareholding pattern disclosure for the period ending June 30, 2026, as required under SEBI regulations.
Laxmi Dental disbursed an unsecured loan of ₹0.25 Crore to its subsidiary Signature Smiles Dental Clinic. Outstanding loan balance now stands at ₹1.25 Crore.
Laxmi Dental reported its highest-ever quarterly revenue of ₹74cr (22% YoY) for Q4FY26, driven by record dental lab performance and international expansion.
Laxmi Dental Limited submitted its Annual Secretarial Compliance Report for FY2026. The report notes minor delays in financial filings and KMP resignation disclosures.
Laxmi Dental reported its highest quarterly revenue, recovering from a weak Q3 despite US tariff headwinds and domestic competition. Growth was driven by the dental lab segment and international expansion.
Laxmi Dental reported record quarterly revenue of ₹74 Cr in Q4FY26 with 21.9% YoY growth, driven by dental lab recovery and aligner solutions.